Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Bone Biologics (BBLG) Non Operating Income (2016 - 2025)

Bone Biologics has reported Non Operating Income over the past 2 years, most recently at -$1.5 million for Q4 2017.

  • Quarterly Non Operating Income rose 73.27% to -$1.5 million in Q4 2017 from the year-ago period, while the trailing twelve-month figure was -$4.4 million through Dec 2017, up 52.63% year-over-year, with the annual reading at $983054.0 for FY2025, 820.97% up from the prior year.
  • Non Operating Income was -$1.5 million for Q4 2017 at Bone Biologics, down from -$1.2 million in the prior quarter.
  • Over five years, Non Operating Income peaked at -$359908.0 in Q2 2016 and troughed at -$5.5 million in Q4 2016.